Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators.

por Levesque, M. A., Clark, G. M., Yu, H., Diamandis, E. P.
Publicado 1995

Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination

por Yu, H, Levesque, M A, Clark, G M, Diamandis, E P
Publicado 1999

REporting recommendations for tumour MARKer prognostic studies (REMARK)

por McShane, L M, Altman, D G, Sauerbrei, W, Taube, S E, Gion, M, Clark, G M
Publicado 2005

Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer.

por Yu, H., Levesque, M. A., Khosravi, M. J., Papanastasiou-Diamandi, A., Clark, G. M., Diamandis, E. P.
Publicado 1996

Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis.

por Borg, A., Sigurdsson, H., Clark, G. M., Fernö, M., Fuqua, S. A., Olsson, H., Killander, D., McGurie, W. L.
Publicado 1991

Sex hormone binding globulin and risk factors for breast cancer in a population of normal women who had never used exogenous sex hormones.

por Moore, J. W., Key, T. J., Bulbrook, R. D., Clark, G. M., Allen, D. S., Wang, D. Y., Pike, M. C.
Publicado 1987

A case-control study of cryptorchidism and maternal hormone concentrations in early pregnancy.

por Key, T. J., Bull, D., Ansell, P., Brett, A. R., Clark, G. M., Moore, J. W., Chilvers, C. E., Pike, M. C.
Publicado 1996